Met Inhibitor Capmatinib Plus Egfr Tyrosine Kinase Inhibitor Nazartinib For Egfr-Mutant Non-Small Cell Lung Cancer
E. Felip, V. Minotti, R. Soo, J. Wolf, B. Solomon,D. S. W. Tan,A. Ardizzoni,D. H. Lee, L. V. Sequist, F. Barlesi, L. Paz-Ares,D. Rodriguez-Abreu,M. R. Garcia Campelo, M. Sprauten,L. O'Sullivan Djentuh,R. Belli,S. Glaser,M. Zou,M. Giovannini,J. C-H. Yang Annals of Oncology（2020）
AI 理解论文
溯源树
样例
